{"id":"NCT00424476","sponsor":"Human Genome Sciences Inc.","briefTitle":"A Study of Belimumab in Subjects With Systemic Lupus Erythematosus (SLE)","officialTitle":"A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, 52-Wk Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006, LymphoStat-B™), a Fully Human Monoclonal Anti-BLyS Antibody, in Subjects With Systemic Lupus Erythematosus (SLE)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-05","primaryCompletion":"2009-05","completion":"2010-03","firstPosted":"2007-01-19","resultsPosted":"2011-05-05","lastUpdate":"2016-12-12"},"enrollment":865,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Systemic Lupus Erythematosus"],"interventions":[{"type":"DRUG","name":"Placebo","otherNames":[]},{"type":"DRUG","name":"Belimumab 1 mg/kg","otherNames":["BENLYSTA™ (formerly LymphoStat-B™)"]},{"type":"DRUG","name":"Belimumab 10 mg/kg","otherNames":["BENLYSTA™ (formerly LymphoStat-B™)"]}],"arms":[{"label":"Placebo","type":"PLACEBO_COMPARATOR"},{"label":"Belimumab 1 mg/kg","type":"EXPERIMENTAL"},{"label":"Belimumab 10 mg/kg","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to evaluate the efficacy, safety, tolerability, and impact on quality of life of two different doses of belimumab administered in addition to standard therapy in subjects with active, autoantibody-positive systemic lupus erythematosus (SLE) disease.","primaryOutcome":{"measure":"SLE Responder Index (SRI) Response Rate at Week 52","timeFrame":"Baseline, 52 weeks","effectByArm":[{"arm":"Placebo","deltaMin":43.6,"sd":null},{"arm":"Belimumab 1 mg/kg","deltaMin":51.4,"sd":null},{"arm":"Belimumab 10 mg/kg","deltaMin":57.6,"sd":null}],"pValues":[{"comp":"OG000 vs OG002","p":"0.0006"},{"comp":"OG000 vs OG001","p":"0.0129"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":9},"locations":{"siteCount":92,"countries":["Argentina","Australia","Brazil","Chile","Colombia","Hong Kong","India","Peru","Philippines","Romania","Russia","South Korea","Taiwan"]},"refs":{"pmids":["40256631","39115551","38258369","38216728","35302581","34741731","34628605","34531304","33830377","33568389","32918459","31302695","25396065","23754628","23524886","23213069","22337213","22275291","21296403"],"seeAlso":["https://www.clinicalstudydatarequest.com"]},"adverseEventsSummary":{"seriousAny":{"events":36,"n":287},"commonTop":["Headache","Upper respiratory tract infection","Arthralgia","Influenza","Diarrhoea"]}}